封面
市場調查報告書
商品編碼
1390612

免疫組織化學市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Immunohistochemistry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球免疫組化市場規模達24億美元。展望未來, IMARC Group預計到2028年市場規模將達到38億美元,2022-2028年複合年成長率(CAGR)為7.96%。

免疫組織化學 (IHC) 是一種使用抗體檢查組織樣本中特定抗原的實驗室方法。這些抗體通常與酵素或螢光染料結合,這有助於研究人員在顯微鏡下觀察抗原。 IHC 廣泛用於診斷癌症等慢性疾病,並有助於區分其類型。與識別有限數量的蛋白質、酵素和組織結構的傳統酵素染色技術相比,IHC 涉及特異性抗原抗體反應。因此,它作為醫學研究實驗室和臨床診斷中的關鍵技術而受到關注,以可視化細胞內特定細胞成分的分佈和定位。

免疫組織化學市場趨勢:

冠狀病毒病(COVID-19)的突然發作導致了全球醫療保健危機。這加大了對 IHC 的需求,以實現快速有效的藥物開發和感染診斷。除此之外,患有癌症、腫瘤、肌肉疾病和神經退化性疾病的人數顯著成長是推動市場的另一個關鍵因素。此外,IHC 可以表徵各種生物過程和病理學,包括傷口癒合、免疫反應、組織排斥和生物材料相互作用。因此,確定特定基因產物在基本生物過程中的功能並確認組織中的感染因子越來越受到關注。此外,最近還推出了幾種新型螢光染料、出色的色彩對比、高解析度和同時多色成像。預計這些創新將使免疫螢光顯微鏡成為未來幾年研究細胞層面病理生物學過程的便利工具。

本報告回答的關鍵問題:

  • 迄今為止,全球免疫組化市場表現如何,未來幾年將如何表現?
  • COVID-19 對全球免疫組織化學市場有何影響?
  • 主要區域市場有哪些?
  • 基於產品的市場區隔是什麼?
  • 基於應用程式的市場區隔是什麼?
  • 根據最終用途分類的市場是怎樣的?
  • 產業價值鏈的各個階段是什麼?
  • 該行業的關鍵促進因素和挑戰是什麼?
  • 全球免疫組化市場的結構如何?誰是主要參與者?
  • 產業競爭程度如何?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球免疫組織化學市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:按產品分類的市場區隔

  • 抗體
    • 市場走向
    • 關鍵環節
      • 一抗
      • 二抗
    • 市場預測
  • 裝置
    • 市場走向
    • 關鍵環節
      • 玻片染色系統
      • 組織微陣列
      • 組織處理系統
      • 玻片掃描儀
      • 其他
    • 市場預測
  • 試劑
    • 市場走向
    • 關鍵環節
      • 組織學染色
      • 封閉血清和試劑
      • 顯色底物
      • 固定試劑
      • 穩定劑
      • 有機溶劑
      • 蛋白水解酶
      • 稀釋劑
    • 市場預測
  • 套件
    • 市場走向
    • 市場預測

第 7 章:按應用分類的市場區隔

  • 診斷
    • 市場走向
    • 關鍵環節
      • 癌症
      • 傳染性疾病
      • 心血管疾病
      • 自體免疫疾病
      • 糖尿病
      • 腎臟病
    • 市場預測
  • 藥物檢測
    • 市場走向
    • 市場預測

第 8 章:依最終用途分類的市場區隔

  • 醫院和診斷實驗室
    • 市場走向
    • 市場預測
  • 研究機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章:按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章:價格分析

第14章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc. (Danaher Corporation)
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4404

Abstract

The global immunohistochemistry market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.96% during 2022-2028.

Immunohistochemistry (IHC) is a laboratory method for checking specific antigens in a tissue sample using antibodies. The antibodies generally bind to an enzyme or a fluorescent dye, which helps researchers see an antigen under a microscope. IHC is widely used to diagnose chronic diseases like cancer and aids in distinguishing their types. As compared to conventional enzyme staining techniques that identify a limited number of proteins, enzymes, and tissue structures, IHC involves specific antigen-antibody reactions. As a result, it is gaining traction as a crucial technique in medical research laboratories and clinical diagnostics to visualize the distribution and localization of specific cellular components within cells.

Immunohistochemistry Market Trends:

The sudden onset of coronavirus disease (COVID-19) has led to a global healthcare crisis. This is escalating the need for IHC for quick and effective drug development and diagnosis of the infection. Apart from this, significant growth in the number of individuals who have cancer, tumors, muscle diseases, and neurodegenerative disorders acts as another key factor driving the market. Moreover, IHC can characterize various biological processes and pathologies, including wound-healing, immune response, and tissue rejection and biomaterial interactions. As a result, it is gaining traction to determine the function of specific gene products in fundamental biological processes and confirm infectious agents in tissues. Moreover, several novel fluorescent dyes, excellent color contrast, high resolution, and simultaneous multicolor imaging have been introduced recently. These innovations are anticipated to make immunofluorescence microscopy a convenient tool for studying pathobiological processes at the cellular level in the forthcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunohistochemistry market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, end use.

Breakup by Product:

Antibodies

Primary Antibodies

Secondary Antibodies

Equipment

Slide Staining Systems

Tissue Microarrays

Tissue Processing Systems

Slide Scanners

Others

Reagents

Histological Stains

Blocking sera and Reagents

Chromogenic Substrates

Fixation Reagents

Stabilizers

Organic Solvents

Proteolytic Enzymes

Diluents

Kits

Breakup by Application:

Diagnostics

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Diabetes Mellitus

Nephrological Diseases

Drug Testing

Breakup by End Use:

Hospitals and Diagnostic Laboratories

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunohistochemistry market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohistochemistry market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players